These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10656235)

  • 41. Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies.
    Kim CH; Park JH; Park TS; Baek HS
    Diabetes Care; 2004 Jan; 27(1):288-9. PubMed ID: 14694017
    [No Abstract]   [Full Text] [Related]  

  • 42. Additive effect of aldose reductase Z-4 microsatellite polymorphism and glycaemic control on cataract development in type 2 diabetes.
    Wang Y; Luk AO; Ng MC; Pang CC; Lam V; Lee SC; Lam DS; Choy KW; Ma RC; So WY; Chan JC
    J Diabetes Complications; 2014; 28(2):147-51. PubMed ID: 24360973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
    Kao YL; Donaghue K; Chan A; Knight J; Silink M
    Diabetes; 1999 Jun; 48(6):1338-40. PubMed ID: 10342825
    [No Abstract]   [Full Text] [Related]  

  • 44. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications.
    Demaine AG
    Curr Med Chem; 2003 Aug; 10(15):1389-98. PubMed ID: 12871136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes.
    Warpeha KM; Ah-Fat F; Harding S; Patterson CC; Xu W; Hart PM; Chakravarthy U; Hughes AE
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():174-8. PubMed ID: 10450377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications.
    Patel A; Ratanachaiyavong S; Millward BA; Demaine AG
    Adv Exp Med Biol; 1993; 328():325-32. PubMed ID: 8493909
    [No Abstract]   [Full Text] [Related]  

  • 48. No association of endothelial lipase and aldose reductase polymorphisms with proliferative diabetic retinopathy: Results of the French prospective multicenter REDIAGEN study.
    Henry A; Boigelot T; Moura TF; Leclercq I; Barbe C; Thiery A; Djerada Z; Nazeyrollas P; Clavel C; Cornillet-Lefebvre P; Berrod JP; Creuzot-Garcher C; Meyer L; Gaucher D; Guerci B; Lenoble P; Milazzo S; Perone JM; Arndt C; Durlach V
    Diabetes Metab; 2024 May; 50(3):101533. PubMed ID: 38570135
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetic association of AKR1B1 gene polymorphism rs759853 with diabetic retinopathy risk: A meta-analysis.
    Cao M; Tian Z; Zhang L; Liu R; Guan Q; Jiang J
    Gene; 2018 Nov; 676():73-78. PubMed ID: 30201105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients.
    Watarai A; Nakashima E; Hamada Y; Watanabe G; Naruse K; Miwa K; Kobayashi Y; Kamiya H; Nakae M; Hamajima N; Sekido Y; Niwa T; Oiso Y; Nakamura J
    Diabet Med; 2006 Aug; 23(8):894-9. PubMed ID: 16911628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (CA)(n) dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene is not associated with microangiopathy in Caucasians with long-term diabetes mellitus 1.
    Isermann B; Schmidt S; Bierhaus A; Schiekofer S; Borcea V; Ziegler R; Nawroth PP; Ritz E
    Nephrol Dial Transplant; 2000 Jun; 15(6):918-20. PubMed ID: 10831660
    [No Abstract]   [Full Text] [Related]  

  • 52. Bioinformatics analysis of diabetic retinopathy using functional protein sequences.
    Rao AA; Thota H; Gumpeny RS; Akula A; Changalasetty SB; Challa SR; Ravavarapu T; Akula SP; Divakar Ch; Srinivas K; Das UN
    Med Hypotheses; 2008; 70(1):148-55. PubMed ID: 17548166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
    Mansfield MW; Stickland MH; Carter AM; Grant PJ
    Thromb Haemost; 1994 Jun; 71(6):731-6. PubMed ID: 7974340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of the Aldose Reductase-106TT Genotype with Increased Risk for Diabetic Retinopathy in the Chinese Han Population: An Updated Meta-Analysis.
    Song ZD; Tao Y; Han N; Wu YZ
    Curr Eye Res; 2016 Aug; 41(8):1087-1091. PubMed ID: 26580232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al.
    P K Ng D; Chia KS; Koh D
    Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018
    [No Abstract]   [Full Text] [Related]  

  • 56. Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.
    Park J; Kim H; Park SY; Lim SW; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kwon HM; Choi WS
    Exp Eye Res; 2014 May; 122():13-9. PubMed ID: 24631337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic analysis of aldose reductase in diabetic complications.
    Chung SS; Chung SK
    Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene.
    Heesom AE; Millward A; Demaine AG
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):213-6. PubMed ID: 9489533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aldose reductase and diabetic retinopathy.
    Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
    Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms.
    Thamotharampillai K; Chan AK; Bennetts B; Craig ME; Cusumano J; Silink M; Oates PJ; Donaghue KC
    Diabetes Care; 2006 Sep; 29(9):2053-7. PubMed ID: 16936152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.